Even H. Rustad
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 11
-
- Protein Degradation and Inhibitors 6
- PI3K/AKT/mTOR signaling in cancer 2
- Melanoma and MAPK Pathways 2
- Co-authors
- Anders Sundan (4 shared papers)Anders Waage (4 shared papers)Therese Standal (3 shared papers)Anne‐Marit Sponaas (2 shared papers)Emadoldin Feyzi (1 shared paper)Eileen M. Boyle (2 shared papers)Elli Papaemmanuil (5 shared papers)Malin Hultcrantz (6 shared papers)
- Journals
- Blood Cancer Journal (4 papers)Clinical Cancer Research (3 papers)PLoS ONE (2 papers)Oncotarget (1 paper)Genetics Research (1 paper)
- Partner nations
- United StatesNorwayItaly
In The Last Decade
Even H. Rustad
13 papers receiving 303 citations
Peers
Comparison fields: 5 of 38
- Hematology 214
- Oncology 147
- Genetics 39
- Cancer Research 52
- Immunology 67
Countries citing papers authored by Even H. Rustad
This map shows the geographic impact of Even H. Rustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Even H. Rustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Even H. Rustad more than expected).
Fields of papers citing papers by Even H. Rustad
This network shows the impact of papers produced by Even H. Rustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Even H. Rustad. The network helps show where Even H. Rustad may publish in the future.
Co-authors
The 25 scholars most cited alongside Even H. Rustad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 66 | |
| 2 | 2017 | 41 | |
| 3 | 2020 | 38 | |
| 4 | 2019 | 35 | |
| 5 | 2019 | 32 | |
| 6 | 2015 | 32 | |
| 7 | 2019 | 22 | |
| 8 | 2018 | 20 | |
| 9 | 2020 | 13 | |
| 10 | Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients | 2019 | 4 |
| 11 | 2023 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2022 | 1 |
About Even H. Rustad
Even H. Rustad is a scholar working on Hematology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 13 papers that have together received 306 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (6 papers), Cancer Genomics and Diagnostics (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Melanoma and MAPK Pathways (2 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Hematology (214 citations), Oncology (147 citations), Genetics (39 citations), Cancer Research (52 citations) and Immunology (67 citations). Even H. Rustad has collaborated with scholars based in United States, Norway and Italy. Frequent co-authors include Anders Sundan, Anders Waage, Therese Standal, Anne‐Marit Sponaas, Emadoldin Feyzi, Eileen M. Boyle, Elli Papaemmanuil, Malin Hultcrantz, Ola Landgren and Leonardo A. Meza‐Zepeda. Their work appears in journals such as Blood Cancer Journal, Clinical Cancer Research, PLoS ONE, Oncotarget and Genetics Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.